VANCOCIN HYDROCHLORIDE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Vancocin Hydrochloride, and what generic alternatives are available?
Vancocin Hydrochloride is a drug marketed by Ani Pharms and Steriscience Speclts and is included in six NDAs.
The generic ingredient in VANCOCIN HYDROCHLORIDE is vancomycin hydrochloride. There are twenty-two drug master file entries for this compound. Thirty suppliers are listed for this compound. Additional details are available on the vancomycin hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Vancocin Hydrochloride
A generic version of VANCOCIN HYDROCHLORIDE was approved as vancomycin hydrochloride by FRESENIUS KABI USA on March 17th, 1987.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for VANCOCIN HYDROCHLORIDE?
- What are the global sales for VANCOCIN HYDROCHLORIDE?
- What is Average Wholesale Price for VANCOCIN HYDROCHLORIDE?
Summary for VANCOCIN HYDROCHLORIDE
US Patents: | 0 |
Applicants: | 2 |
NDAs: | 6 |
Finished Product Suppliers / Packagers: | 2 |
Raw Ingredient (Bulk) Api Vendors: | 50 |
Clinical Trials: | 35 |
Patent Applications: | 20 |
DailyMed Link: | VANCOCIN HYDROCHLORIDE at DailyMed |
Recent Clinical Trials for VANCOCIN HYDROCHLORIDE
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
National Institute of Allergy and Infectious Diseases (NIAID) | Phase 4 |
Alexander Flannery | Phase 4 |
Memorial University of Newfoundland | Phase 3 |
Pharmacology for VANCOCIN HYDROCHLORIDE
Drug Class | Glycopeptide Antibacterial |